Anti-Smad4 antibody [EPR22589-112]
- RabMAb
- Recombinant
- KO Validated
- Advanced Validation
- 20ul selling size
- What is this?
5
(1 Review)
|
(15 Publications)
Rabbit Recombinant Monoclonal SMAD4 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), ChIC/CUT&RUN-seq and reacts with Mouse, Human, Rat samples. Cited in 15 publications.
View Alternative Names
DPC4, MADH4, SMAD4, SMAD family member 4, SMAD 4, hSMAD4, Deletion target in pancreatic carcinoma 4, Mothers against decapentaplegic homolog 4, MAD homolog 4, Mothers against DPP homolog 4
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Smad4 antibody [EPR22589-112] (AB230815)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed Smad4 KO HAP1 (Smad4 knockout human chronic myelogenous leukemia near-haploid cell line, Left) / WT HAP1 (human chronic myelogenous leukemia near-haploid cell line, Right) cell line labeling Smad4 with ab230815 at 1/500 (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat anti rabbit IgG (Alexa Fluor� 488, ab150077) was used as secondary antibody at 1/2000 dilution.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Smad4 antibody [EPR22589-112] (AB230815)
Immunofluorescent analysis of HeLa (human cervix adenocarcinoma epithelial cell) cells labeling Smad4 with ab230815 at a 1/100 dilution (green). Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Confocal image showing mainly nuclear staining in HeLa cell line treated with TGF-beta (10ng/ml) for 1 h. AlexaFluor®488 Goat anti-Rabbit (ab150077) was used secondary antibody at 1/1000 dilution, this was also used on its own as a control. DAPI was used as a nuclear counterstain (blue). Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594, ab195889) was used as a counterstain at 1/200 dilution.
- IP
Unknown
Immunoprecipitation - Anti-Smad4 antibody [EPR22589-112] (AB230815)
Smad4 was immunoprecipitated from 0.35mg of HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate with ab230815 at 1/30 dilution. Western Blot was performed from the immunoprecipitate using ab230815 at 1/1000 dilution (0.5 μg/ml).
VeriBlot for IP Detection Reagent (HRP) (ab131366), was used as secondary antibody at 1/5000 dilution.
Lane 1 : HeLa whole cell lysate 10μg (Input).
Lane 2 : ab230815 IP in HeLa whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab230815 in HeLa whole cell lysate
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 30 seconds
Lysate was freshly prepared and IP test was done immediately to avoid protein degradation. Lysate incubation time was shortened from overnight to 2h.
All lanes:
Immunoprecipitation - Anti-Smad4 antibody [EPR22589-112] (ab230815)
Predicted band size: 60 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-Smad4 antibody [EPR22589-112] (AB230815)
Smad4 was immunoprecipitated from 0.35mg of NIH/3T3 (mouse embryonic fibroblast) whole cell lysate with ab230815 at 1/30 dilution. Western Blot was performed from the immunoprecipitate using ab230815 at 1/1000 dilution (0.5 μg/ml).
VeriBlot for IP Detection Reagent (HRP) (ab131366), was used as secondary antibody at 1/5000 dilution.
Lane 1 : NIH/3T3 whole cell lysate 10μg (Input).
Lane 2 : ab230815 IP in NIH/3T3 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab230815 in NIH/3T3 whole cell lysate
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 10 seconds
Lysate was freshly prepared and IP test was done immediately to avoid protein degradation. Lysate incubation time was shortened from overnight to 2h.
All lanes:
Immunoprecipitation - Anti-Smad4 antibody [EPR22589-112] (ab230815)
Predicted band size: 60 kDa
false
- WB
Unknown
Western blot - Anti-Smad4 antibody [EPR22589-112] (AB230815)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure Time : Lanes 1-6 : 15 secs; Lanes 7-8 : 114 secs; Lane 9 : 3 mins.
ab230815 was shown to specifically react with Smad4 in wild-type HAP1 cells as signal was lost in Smad4 knockout cells. Wild-type and Smad4 knockout samples were subjected to SDS-PAGE. ab230815 and ab181602 (Rabbit anti-GAPDH loading control) were incubated 1 hour at room temperature at 1/1000 dilution and 1/200,000 dilution respectively. Blots were developed with Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) secondary antibody at 1/100,000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Smad4 antibody [EPR22589-112] (ab230815) at 1/1000 dilution
Lane 1:
Smad4 knockout HAP1 whole cell lysate at 20 µg
Lane 2:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 3:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 4:
HCT116 (human colorectal carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 5:
HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 6:
Human fetal lung tissue lysate at 20 µg
Lane 7:
Mouse embryo tissue lysate at 20 µg
Lane 8:
Mouse lung tissue lysate at 20 µg
Lane 9:
Rat lung tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 60 kDa
Observed band size: 60 kDa
false
- WB
Supplier Data
Western blot - Anti-Smad4 antibody [EPR22589-112] (AB230815)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1 : 15 secs; Lane 2 : 7.75 secs.
All lanes:
Western blot - Anti-Smad4 antibody [EPR22589-112] (ab230815) at 1/1000 dilution
Lane 1:
HEK-293 (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 60 kDa
Observed band size: 60 kDa
false
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-Smad4 antibody [EPR22589-112] (AB230815)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 105 HeLa (Human epithelial cell line from cervix adenocarcinoma) cells treated with hTGF-β1 (10 ng/mL 1 h) and 5 µg of ab230815 [EPR22589-112]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-Smad4 antibody [EPR22589-112] (AB230815)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 105 HeLa (Human epithelial cell line from cervix adenocarcinoma) cells treated with hTGF-β1 (10 ng/mL 1 h) and 5 µg of ab230815 [EPR22589-112]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-Smad4 antibody [EPR22589-112] (AB230815)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 105 HeLa (Human epithelial cell line from cervix adenocarcinoma) cells treated with hTGF-β1 (10 ng/mL 1 h) and 5 µg of ab230815 [EPR22589-112]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- WB
Unknown
Western blot - Anti-Smad4 antibody [EPR22589-112] (AB230815)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Smad4 antibody [EPR22589-112] (ab230815) at 1/1000 dilution
Lane 1:
RAW264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg
Lane 2:
NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 60 kDa
false
Exposure time: 48s
- WB
CiteAb
Western blot - Anti-Smad4 antibody [EPR22589-112] (AB230815)
Smad4 western blot using anti-Smad4 antibody [EPR22589-112] ab230815. Publication image and figure legend from Song, Y., Wang, Z., et al., 2020, J Cell Mol Med, PubMed 33124760.
ab230815 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab230815 please see the product overview.
Effects of DEK shRNA on Smad, MAPK and PI3K/AKT signalling pathways in BEAS-2B cells. (A-E) The expressions of TGF-β, DEK mad2/3 and Smad4, ERK1/2, p38, JNK, and PI3K, AKT, mTOR were detected by Western blot. The relative density of each protein was calculated. Data were shown as mean ± SD (n = 3). NC, negative control cells; ovDEK, cells transfected with DEK; shNC, cells transfected with scrambled shRNA; shDEK, cells transfected with DEK shRNA. *p < 0.05, vs control group. #p < 0.05, ovDEK vs TGF-β1 + NC group; shDEK vs TGF-β1 + shNC group
false
Related conjugates and formulations (1)
-
Anti-Smad4 antibody [EPR22589-112] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Smad4 influences cell proliferation differentiation and apoptosis by mediating signals from TGF-beta cytokines. It is part of the Smad protein family acting as a transcriptional controller. Upon TGF-beta receptor activation Smad4 forms complexes with Smad2 and Smad3 translocating to the nucleus to regulate genes imperative for cellular homeostasis. Its role in cell cycle regulation underlines its contribution to normal cellular functions and its potential involvement in disorders.
Pathways
Smad4 operates within the TGF-beta pathway linking extracellular signals to nuclear transcription alterations. It participates in the regulation of epithelial-mesenchymal transition (EMT) a process important for development and tumor progression. In these pathways Smad4 interacts closely with Smad2 and Smad3 orchestrating various cellular responses to external stimuli through transcriptional management.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (15)
Recent publications for all applications. Explore the full list and refine your search
Cell biology and toxicology 41:105 PubMed40524087
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:18460 PubMed40425777
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of molecular histology 56:128 PubMed40178733
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed39062881
2024
Applications
Unspecified application
Species
Unspecified reactive species
NPJ Regenerative medicine 8:6 PubMed36759627
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed36614063
2022
Applications
Unspecified application
Species
Unspecified reactive species
Atherosclerosis plus 50:57-64 PubMed36643802
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2022:8002566 PubMed35707278
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:1459-1475 PubMed35258414
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:227-241 PubMed34847839
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com